Scholar Rock Holding Corp (SRRK)
26.67
-1.19
(-4.27%)
USD |
NASDAQ |
Nov 21, 16:00
26.69
+0.02
(+0.07%)
After-Hours: 20:00
Scholar Rock Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2022 | 33.19M |
| December 31, 2021 | 4.049M |
| September 30, 2021 | 5.464M |
| June 30, 2021 | 4.595M |
| March 31, 2021 | 4.708M |
| December 31, 2020 | 3.436M |
| September 30, 2020 | 3.037M |
| Date | Value |
|---|---|
| June 30, 2020 | 3.90M |
| March 31, 2020 | 5.03M |
| December 31, 2019 | 7.573M |
| September 30, 2019 | 4.774M |
| June 30, 2019 | 5.039M |
| March 31, 2019 | 3.106M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
3.037M
Minimum
Sep 2020
33.19M
Maximum
Mar 2022
7.498M
Average
4.652M
Median
Revenue (Quarterly) Benchmarks
| Cytokinetics Inc | 0.463M |
| Regeneron Pharmaceuticals Inc | 3.721B |
| Ocugen Inc | 1.136M |
| Mirum Pharmaceuticals Inc | 90.38M |
| NeuroBo Pharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -64.48M |
| Total Expenses (Quarterly) | 64.78M |
| EPS Diluted (Quarterly) | -0.66 |
| Enterprise Value | 2.408B |
| Earnings Yield | -8.81% |
| Normalized Earnings Yield | -11.40 |